Next-Gen CAR T & Novel SMA Drug Among New Entrants On EMA’s PRIME
Rare Pediatric Disease Drug & Multiple Myeloma Therapy Also Make The Grade
Autolus says its investigational treatment may overcome limitations of other CAR T-cell therapies • Source: Shutterstock 
